[A case of acute erythroblastic anemia due to infection with human parvovirus B19 after coronary artery bypass grafting].
A 37-year-old male developed reticulocytopenia and leukopenia with fever from the 11th patient day after coronary artery bypass grafting. Bone-marrow puncture revealed a marked decrease of erythroblasts and appearance of giant proerythroblasts. Thus, infection with human parvovirus B 19 (HPV-B 19) was suspected. At the onset of the disease, only IgM antibody was positive, but later IgG antibody also turned positive, and DNA of HPV-B19 was detected by polymerase chain reaction (PCR) from the bone marrow specimen of the patient. Then the patient was diagnosed with acute erythroblastic anemia due to infection with HPV-B19. In this case, DNA of HPV-B19 was detected by PCR from a fibrin sealant used during operation. The fibrin sealant was found to be the source of infection. Fibrin sealants are used widely in the domain of surgery. Therefore, we should perform screening of plasma and make examination of the sealants, while paying attention to infections with HPV-B 19 in the future.
Enoki
C
C
Department of Cardiovascular Surgery, Shizuoka Red Cross Hospital, Shizuoka, Japan.
Higashi
S
S
Oohata
M
M
Tanaka
T
T
D000328:Adult; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D023921:Coronary Stenosis / Q000601:surgery; D015718:Fibrin Tissue Adhesive / Q000009:adverse effects; D006801:Humans; D008297:Male; D010322:Parvoviridae Infections / Q000150:complications*; D016732:Parvovirus B19, Human; D011183:Postoperative Complications; D017086:beta-Thalassemia / Q000209:etiology*
D015718:Fibrin Tissue Adhesive